Related Experiment Video
Updated: Feb 22, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.8K
Targeting Metabolism for Cancer Therapy
Alba Luengo1, Dan Y Gui1, Matthew G Vander Heiden2
1The Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Cell Chemical Biology
|September 23, 2017
Summary
Cancer cells reprogram their metabolism for growth, creating vulnerabilities exploitable by targeted therapies. Understanding these metabolic dependencies offers new strategies for effective cancer treatment.
Area of Science:
- Oncology
- Metabolic pathways
- Cancer biology
Background:
- Metabolic reprogramming is a hallmark of cancer, driving tumor development.
- Targeting cancer metabolism with chemotherapy has a long history of success, validating a therapeutic window.
- Altered metabolic dependencies in tumors present novel targets for cancer therapy.
Purpose of the Study:
- To review the current understanding of cancer metabolism.
- To discuss how insights into cancer metabolism can guide the development of new therapeutic strategies.
- To highlight the potential of targeting tumor-specific metabolic liabilities.
Main Methods:
- Literature review of cancer metabolism research.
- Analysis of current therapeutic strategies targeting metabolic pathways.
- Discussion of preclinical and clinical evaluations of novel metabolic therapies.
Main Results:
- Cancer cells exhibit significant metabolic alterations compared to normal cells.
- Exploiting these metabolic differences offers a promising avenue for cancer treatment.
- Several novel therapeutic strategies targeting cancer metabolism are under investigation.
Conclusions:
- Targeting the unique metabolic requirements of tumor cells is a viable therapeutic approach.
- Continued research into cancer metabolism will yield new and improved treatments.
- Exploiting metabolic liabilities represents a key strategy in modern oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:46Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:18Cancer
54.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.8K